Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran
Format: Artigo
Jezik:Inglês
Izdano: Croatian Medical Schools 2014
Teme:
Cerebrospinal Fluid Physiology and Movement
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://ncbi.nlm.nih.gov/pubmed/25165049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2014.55.347
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items